The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic solution and drug-free solution to safely and effectively prevent or delay the progression of nuclear cataracts that frequently develop as a result of vitrectomy (surgery for retina repair), thereby avoiding the need for a second surgery (cataract removal). Victrectomies involve removal of the jelly-like substance (vitreous) that is located in a cavity behind the lens.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
164
Unnamed facility
Peoria, Arizona, United States
Unnamed facility
Beverly Hills, California, United States
Unnamed facility
Sacramento, California, United States
change in visual acuity
change in lens opacity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Miami, Florida, United States
Unnamed facility
Tallahassee, Florida, United States
Unnamed facility
Chicago, Illinois, United States
Unnamed facility
Joliet, Illinois, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Cherry Hill, New Jersey, United States
...and 6 more locations